GlassScriptPhysician profile
Antoine Marc
NPI 1033798004
$2,084.34
in general payments reported to CMS, 2019-2025
10 companies · $388 in 2025
The $388 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $105 · 2023: $1,334 · 2024: $258 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,740 · Education: $240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,739.72 |
| Education | $239.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $697.90 | 2023-2025 | Treo Abdominal Stent-Graft System, Thoraflex Hybrid |
| Medtronic, INC. | $393.09 | 2023 | Endurant Iis |
| Abbott Laboratories | $329.41 | 2023 | Xact, Jeti, Supera |
| Silk Road Medical, INC. | $255.40 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Cardiva Medical, INC. | $119.64 | 2023 | Cardiva Vascade 6/7f Vcs |
| Cardiovascular Systems INC. | $104.63 | 2022 | |
| Terumo Medical Corporation | $100.00 | 2023 | Angio-Seal, Azur Cx Detachable |
| Penumbra, INC. | $47.87 | 2025 | Indigo System |
| Boston Scientific Corporation | $18.62 | 2023 | Eluvia |
| Ethicon US, LLC | $17.78 | 2024 | Dermabond |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antoine Marc listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.